One participant stated: "While on Mounjaro, I couldn't smoke, but after stopping it for about a month, I went back to smoking." (Male, 8 months on GLP-1 therapy) "During the period of use, the need for nicotine noticeably decreased, but after the treatment period ended, the desire to smoke gradually increased." (Male, 6 months on GLP-1 therapy) In contrast, a subset of participants reported no observable perceived impact of GLP-1 on their smoking behavior
GLP-1 receptor agonists are all over television ads, talked about constantly, and have become very popular prescription drugs
In 2014, the US Food and Drug Administration (FDA) acknowledged a GRAS (Generally Recognised as Safe) notification for AOD 9604 as a food ingredient meaning the FDA raised no questions about the notifier's own safety conclusion
We could trigger weight loss signals that happen later in the pathway more directly. A new company called CoronationBio has been launched to turn this discovery into a real-world treatment
Prioritize Sleep: Your body does its most significant "cleanup" work while you are asleep
